Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 4, 2016

View Archived Issues

KemPharm unveils oxymorphone prodrug KP-746

FDA grants orphan drug designation to GBT-440 for sickle cell disease

First-in-human results show antimyeloma activity of CAR-BCMA cells

Dysregulation of KDM6B has a role in alcohol dependence

Incyte patents PI3Kdelta inhibitors

Araim Pharmaceuticals and Vault Bioventures form partnership to develop ARA-290 and other peptides

New phase II trial explores ramucirumab for advanced, pretreated biliary cancers

Auxilium to return U.S. and Canadian rights for Stendra to Vivus

Merck & Co. initiates phase II trial of pembrolizumab in B-cell lymphoma

FDA grants orphan drug designation to Pluristem's PLX-PAD for severe preeclampsia

New class of TCBs shows promising preclinical results in multiple myeloma

NIH grant supports work at MUSC into pancreatitis and diabetes

New potential biomarkers for DLBCL

Acerus Pharmaceuticals to terminate Natesto commercialization agreement with Endo

TPIV-100 vaccination boosts T-cell immunity in breast cancer

Dyadic International sells industrial technology business and will focus on biopharmaceuticals

New prophylactic compound shows safety and efficacy to prevent bleedings in hemophilia B patients

Platinum chemotherapeutic shows promise for TNBC

Gilead Sciences studies ledipasvir/sofosbuvir for chronic HCV and HBV coinfection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...